A Phase IIa, Double Blind, Randomized, Placebo Controlled, Parallel, Multicentre, Proof‐of‐Concept Study to Evaluate the Efficacy and Safety of Desidustat Oral Tablet for Treatment of Sickle Cell Disease
Mohit Desai, Bhargav Solanki, Manish Hathila, Vikas Asati, Suchi Shah, Deven Parmar et al. A Phase IIa, Double Blind, Randomized, Placebo Controlled, Parallel, Multicentre, Proof‐of‐Concept Study to Evaluate the Efficacy and Safety of Desidustat Oral Tablet for Treatment of Sickle Cell Disease. // European Journal of Haematology. – 2026. – DOI: 10.1111/ejh.70296. – URL: https://onlinelibrary.wiley.com/doi/10.1111/ejh.70296?af=R
Mohit Desai, Bhargav Solanki, Manish Hathila, Vikas Asati, Suchi Shah, Deven Parmar, Sanjay Vekariya, Kevinkumar Kansagra, Mayank Gangwar, Gunjan Kumar, Sudipto Roy, & Aparna Mukherjee (2026). A Phase IIa, Double Blind, Randomized, Placebo Controlled, Parallel, Multicentre, Proof‐of‐Concept Study to Evaluate the Efficacy and Safety of Desidustat Oral Tablet for Treatment of Sickle Cell Disease. European Journal of Haematology. https://doi.org/10.1111/ejh.70296
Mohit Desai, et al. “A Phase IIa, Double Blind, Randomized, Placebo Controlled, Parallel, Multicentre, Proof‐of‐Concept Study to Evaluate the Efficacy and Safety of Desidustat Oral Tablet for Treatment of Sickle Cell Disease.” European Journal of Haematology, 2026. doi:10.1111/ejh.70296.
@article{Desai2026,
title = {A Phase IIa, Double Blind, Randomized, Placebo Controlled, Parallel, Multicentre, Proof‐of‐Concept Study to Evaluate the Efficacy and Safety of Desidustat Oral Tablet for Treatment of Sickle Cell Disease},
author = {Desai, Mohit and Solanki, Bhargav and Hathila, Manish and Asati, Vikas and Shah, Suchi and Parmar, Deven and Vekariya, Sanjay and Kansagra, Kevinkumar and Gangwar, Mayank and Kumar, Gunjan and Roy, Sudipto and Mukherjee, Aparna},
journal = {European Journal of Haematology},
year = {2026},
doi = {10.1111/ejh.70296},
url = {https://onlinelibrary.wiley.com/doi/10.1111/ejh.70296?af=R}
}